Table 2. Stratified pooled relative risks and 95% confidence intervals for highest versus lowest category of dietary beta-carotene and all-cause mortality.
Subgroups | N | Death | Participants | RR | 95%CI | I2 (%) | Pa | Pb | |
---|---|---|---|---|---|---|---|---|---|
All studies | 7 | 11810 | 149774 | 0.83 | 0.78, 0.88 | 1.00 | 0.416 | ||
Duration of follow-up | 0.144 | ||||||||
<10 years | 5 | 4133 | 88170 | 0.89 | 0.80, 0.98 | 0 | 0.555 | ||
> = 10 years | 2 | 7677 | 61604 | 0.79 | 0.73, 0.86 | 0 | 0.826 | ||
Sample size | 0.902 | ||||||||
<10,000 | 3 | 1519 | 14341 | 0.83 | 0.70, 0.97 | 0 | 0.928 | ||
> = 10,000 | 4 | 10291 | 135433 | 0.84 | 0.75, 0.94 | 49.30 | 0.116 | ||
Population age at baseline | 0.255 | ||||||||
<50 | 4 | 4434 | 86131 | 0.87 | 0.78, 0.97 | 14.50 | 0.320 | ||
> = 50 | 3 | 7376 | 63643 | 0.80 | 0.74, 0.86 | 0 | 0.843 | ||
Median intake | 0.519 | ||||||||
<2500 ug/d | 3 | 1762 | 48684 | 0.80 | 0.69, 0.92 | 0 | 0.722 | ||
> = 2500 ug/d | 3 | 9729 | 94075 | 0.86 | 0.75, 0.99 | 60.80 | 0.078 | ||
Validated FFQ | 0.751 | ||||||||
Yes | 4 | 10019 | 130819 | 0.83 | 0.74, 0.93 | 42.70 | 0.155 | ||
No | 3 | 1791 | 18955 | 0.85 | 0.73, 1.00 | 0 | 0.741 | ||
Major confounders adjusted | |||||||||
History of disease | 0.071 | ||||||||
Yes | 4 | 3571 | 46812 | 0.79 | 0.73, 0.85 | 0 | 0.852 | ||
No | 3 | 8239 | 102962 | 0.92 | 0.82, 1.03 | 0 | 0.920 | ||
Smoking and drinking | 0.837 | ||||||||
Yes | 5 | 10309 | 131994 | 0.83 | 0.76, 0.91 | 25.60 | 0.251 | ||
No | 2 | 1501 | 17780 | 0.85 | 0.72, 1.00 | 0 | 0.451 | ||
Physical activity | 0.158 | ||||||||
Yes | 4 | 8210 | 109615 | 0.80 | 0.74, 0.86 | 0 | 0.629 | ||
No | 3 | 3600 | 40159 | 0.89 | 0.80, 1.00 | 0 | 0.457 | ||
Serum cholesterol level | 0.751 | ||||||||
Yes | 3 | 1791 | 18955 | 0.85 | 0.73, 1.00 | 0 | 0.741 | ||
No | 4 | 10019 | 130819 | 0.83 | 0.74, 0.93 | 42.70 | 0.155 | ||
Vitamin supplementation use | 0.302 | ||||||||
Yes | 2 | 7057 | 56628 | 0.79 | 0.73, 0.86 | 0 | 0.574 | ||
No | 5 | 4753 | 93146 | 0.87 | 0.79, 0.96 | 0 | 0.461 |
Abbreviation: RR, relative risk; CI, confidence interval; I 2, measure of heterogeneity; Pa, P value for heterogeneity within each group; Pb, P value for heterogeneity between subgroups in meta-regression.